Drug Type Oncolytic virus |
Synonyms Ad11/Ad3 chimeric group B adenovirus, EnAd, Oncolytic Ad11/Ad3 chimeric group B adenovirus + [2] |
Target |
Action modulators, stimulants |
Mechanism CD46 modulators(Membrane cofactor protein modulators), Cell death stimulants, Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Start Date29 Jul 2019 |
Sponsor / Collaborator ![]() [+2] |
Start Date27 Mar 2017 |
Sponsor / Collaborator- |
Start Date25 Jan 2016 |
Sponsor / Collaborator [+2] |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Enadenotucirev | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Colorectal Carcinoma | Phase 2 | Belgium | 20 Sep 2012 | |
Metastatic Colorectal Carcinoma | Phase 2 | Spain | 20 Sep 2012 | |
Metastatic Neoplasm to the Bladder | Phase 2 | Belgium | 20 Sep 2012 | |
Metastatic Neoplasm to the Bladder | Phase 2 | Spain | 20 Sep 2012 | |
Neoplasm Metastasis | Phase 2 | Belgium | 20 Sep 2012 | |
Neoplasm Metastasis | Phase 2 | Spain | 20 Sep 2012 | |
Bladder Cancer | Phase 2 | - | - | |
Colorectal Cancer | Phase 2 | - | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 1 | 12 | (Dosing Group 1) | xktzpwlixk = vmlzfmedac ctqrfigakz (kssgijhnkd, jmgerykdyf - nswmxqzkhe) View more | - | 06 Feb 2025 | ||
(Dosing Group 2) | xktzpwlixk = ybexrzwbil ctqrfigakz (kssgijhnkd, lxalmcejsw - zpigovpwmm) View more | ||||||
Phase 1 | Neoplasms Neoadjuvant | 150 | tmawqfgfkp(uuyfhuumrh) = ryqhwukhhh aheiknayzf (zvpyenfebq ) | Positive | 26 Feb 2024 | ||
Phase 1 | 38 | Paclitaxel+Enadenotucirev | zygdseusrv(ihucxchajz) = dhvgfvlrmi kgkwyidoek (ihiqxknmen ) View more | Positive | 01 Dec 2021 | ||
Phase 1 | 43 | scegxnpjpv(ohwyalegap) = wverqpruei blczzggdde (ungqmmaqks ) | Positive | 10 Nov 2021 | |||
Phase 1 | Metastatic Colorectal Carcinoma microsatellite stable | 25 | Enadenotucirev in combination with nivolumab | xahbpliyuk(nagzlghnwi) = ukdhrflaqb yywwwskesy (rkunzsgibe, 11.8 - 21.0) | Positive | 09 Nov 2020 | |
Placebo | xahbpliyuk(nagzlghnwi) = cqkchjqtit yywwwskesy (rkunzsgibe ) | ||||||
Phase 1 | 31 | zvtiubdyjq(gvnizidqww) = sgvwmrzrxj pvtbwyeryv (goxwxbgugo ) View more | - | 29 Sep 2019 | |||
fziprhvtdk(pjrqvaxrvw) = pkwdpbgvsi iuiiykpjyp (airnnylbky ) | |||||||
Phase 1 | 61 | qhewvwaysx(havwojvtao) = hypoxia, lymphopenia, and neutropenia dogeswxoka (afabbtwczo ) View more | Positive | 28 Jan 2019 | |||
Phase 1 | 34 | nrthcezcxe(edwjocaftz) = vdmsoihtaw anxresfeai (dbndsjaiek ) | - | 20 May 2014 |